Item 5.02. Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers

Joan E. Miller, Senior Vice President, Pathology and Neurology, of Quest Diagnostics Incorporated (the "Company") terminated employment on October 31, 2012 in connection with the Company's recently-announced management restructuring aimed at driving operational excellence and restoring growth. In connection with her termination of employment, Dr. Miller will be entitled to benefits under the Company's Executive Officer Severance Plan, in which she is a Schedule A participant. The Company's Executive Officer Severance Plan was filed as Exhibit 10.1 to the Company's Current Report on Form 8-K filed with the Securities and Exchange Commission on May 16, 2012.

Dr. Miller agreed to provide consulting services to the Company for the six month period after her termination of employment. The Company will pay to Dr. Miller $209,496 for her services under the consulting agreement. The foregoing description of the consulting agreement is qualified in its entirety by reference to the full text of the consulting agreement, which is filed as Exhibit 10.1 to this Current Report on Form 8-K and incorporated by reference herein.

Item 9.01. Financial Statements and Exhibits

d. Exhibit Description

10.1 Consulting Agreement dated October 31, 2012 between Quest Diagnostics Incorporated and Joan E. Miller

---